Pharmaceuticals
Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.
Pharmaceuticals
Filters
Refine your search
API designed for use in pharmaceutical products.Benefits:
- Meets with EP, USP, Ch.P and BP specifications
TDS
API designed for use in animal pharmaceutical products. Benefits:
- Complies with US VMF, CA VMF, CEP and WHO DMF specifications
- USP, EP and CVP certified
TDS
API designed for use in pharmaceutical applications.Benefits:
- Complies with the specifications of EP10
TDS
API suitable for pharmaceutical preparations.Benefits:
- Complies with the specifications of EP10
TDS
Oxytetracycline dihydrate designed for pharmaceutical
applications. It is suitable for injectable forms.Benefits:
- Meets with EP and USP specifications
- FDA certified
TDS
Oxytetracycline hydrochloride designed for pharmaceutical
applications. It is suitable for injections. Shelf life: 3 years.Benefits:
- Meets with EP 10 specifications
TDS
Melatonin - Impurity D for use in pharmaceutical
applications.Benefits:
- Complies with EP/BP specifications
TDS
Ibuprofen - Impurity B (sodium salt) used in pharmaceutical
applications.Benefits:
- Complies with EP/BP specifications
TDS
Ibuprofen - Impurity N used in pharmaceutical applications.Benefits:
- Complies with EP/BP specifications
TDS
API developed for pharmaceutical injection formulations. It
is β-lactam enzyme inhibitor to treat upper and lower respiratory tract
infections. It is suitable for urinary tract infections, skin and soft tissue
infections. Benefits:
- Freely soluble in water
- Sterile as per Ph. Eur.
TDS
API designed for pharmaceutical injection formulations. It
is β-lactam enzyme inhibitor to treat upper and lower respiratory tract
infections. It is suitable for urinary tract infections, skin and soft tissue
infections. Benefits:
- Freely soluble in water
- Sterile as per Ph. Eur.
TDS
API developed for pharmaceutical injection formulations. It
is semi-synthetic penicillin to treat upper and lower respiratory tract
infections. It is suitable for genitourinary tract infections, skin and soft
tissue infections. It is applicable in the treatment of typhoid fever and
leptospirosis. Benefits:
- Sterile
- Conforms to EP…
TDS
API developed for pharmaceutical formulations. It
is semi-synthetic penicillin to treat upper and lower respiratory tract
infections. Benefits:
- Complies with USP, EP and BP
- Meets with DMF, US DMF and CEP specifications
TDS
API designed for pharmaceutical applications. It is semi-synthetic
penicillin. It is used to treat bacterial infections.
Benefits:
- Available in micronized powder
- Complies with USP, EP and BP
- Meets with DMF, US DMF and CEP specifications
TDS
API designed for pharmaceutical applications. It is semi-synthetic
penicillin. It is used to treat bacterial infections.Benefits:
- Available in white crystalline powder
- Complies with USP, EP and BP
- Meets with DMF, US DMF and CEP regulations
TDS
API designed for use in pharmaceutical formulations. It is semi-synthetic
penicillin. It is used to treat bacterial infections.Benefits:
- Available in crystalline powder form
- Complies with USP, BP and EP
- Meets with DMF, US DMF and CEP specifications
TDS
Henan Lihua Pharmaceutical
Henan Lihua Pharmaceutical Co., Ltd., was founded in 1994, used to employ Diosgenin as starting material to develop various corticosteroid APIs, which was very rich in China. In recent years, the company strived to make transformation since the lack of Diosgenin and rising costs in China and succeeded finally. Now the company takes phytosterol as starting material to manufacture various of corticosteroid APIs and related core intermediates, with latest fermentation and chemical synthesis technologies. Products quality meet the following pharmacopeia specifications: Ph.Eur., USP, JP, IP and Ch.P. and products are sold all over the world.
Hisun Pharmaceutical
Hisun Pharma, founded in 1956, now is the one of the leading pharmaceutical manufactures in China. We are inspected by USFDA, EDQM, HPFB, TGA, APVMA, DCGI, etc.. We have broad portfolio of APIs including Oncology, Cardiovascular, Anti-infectives，Anti-parasitic, etc.
Jiangxi Tianxin
Jiangxi Tianxin Pharmaceutical Co., Ltd. is established in September 2004, a high-tech company specializing in vitamin production, providing products of Vitamin B6, Vitamin B1, Folic Acid, Biotin and Vitamin D3 which are widely used as API, food additives, feed additives and in other fields.
Dc Pharma
Hebei Shengxue Dacheng Pharmaceuticat Co., Ltd founded in 1997, is a large pharmaceutical company focusing on producing and marketing antibiotics, feed additives and premixes. Our company is state owned and subordinate to China National Nuclear Corporation. We set up two wholly-owned subsidiaries - Hebei Shengxue Dacheng Pharmaceutical (Tangshan) Co., Ltd and Hebei Hongcheng Yaxin Technology Co.,Ltd.
Pharmaffiliates Analytics & Synthetics
Pharmaffiliates Analytics and Synthetics P. Ltd., a Research Based Organization is a gigantic name in the global market, which offers services to Pharmaceutical industry, Biotechnology industry, API manufacturers, Bulk drug suppliers, clinical CROs, Research institutes and other allied industries.
Started in the year 2001 as a research based organization, Pharmaffiliates is known in the industry for its state of the art research and development center, located in the North Indian state of Haryana, India.
With a core team of our subject matter experts which is a blend of highly experienced and learned scientists along with young and dynamic associates, Pharmaffiliates main focus is on synthetic research, analytical research, NDDS and regulatory consulting.
Zhuhai United Laboratories
Founded in Hong Kong in 1990, The United Laboratories(TUL) is operating for over two decades, now TUL is positioned as one of the largest antibiotic pharmaceutical companies in the world. Considering that 100% of its capital is owned by Hong Kong Shareholders, TUL is currently structured into three Divisions: API and Intermediate Production, Biopharmaceutical products, Production formulation.
